Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025
Compare Balance Sheet Results of Brawn Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.00
4.00
-1.00
-25.00%
Share Warrants & Outstandings
Total Reserve
1.34
0.40
0.94
235.00%
Shareholder's Funds
4.34
4.40
-0.06
-1.36%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.28
-0.28
-100.00%
Secured Loans
0.00
0.10
-0.10
-100.00%
Unsecured Loans
0.00
0.18
-0.18
-100.00%
Deferred Tax Assets / Liabilities
-1.45
0.00
-1.45
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
1.29
0.00
1.29
0.00%
Long Term Provisions
0.06
0.00
0.06
0.00%
Total Non-Current Liabilities
-0.11
0.88
-0.99
-112.50%
Current Liabilities
Trade Payables
14.41
6.07
8.34
137.40%
Other Current Liabilities
0.70
0.11
0.59
536.36%
Short Term Borrowings
0.00
6.62
-6.62
-100.00%
Short Term Provisions
0.06
0.16
-0.10
-62.50%
Total Current Liabilities
15.17
12.95
2.22
17.14%
Total Liabilities
19.40
18.23
1.17
6.42%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.05
0.19
0.86
452.63%
Less: Accumulated Depreciation
0.69
0.07
0.62
885.71%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.36
0.12
0.24
200.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
1.91
-1.91
-100.00%
Long Term Loans & Advances
0.00
0.59
-0.59
-100.00%
Other Non Current Assets
1.92
0.00
1.92
0.00%
Total Non-Current Assets
2.28
2.63
-0.35
-13.31%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
10.06
2.95
7.11
241.02%
Sundry Debtors
3.55
10.66
-7.11
-66.70%
Cash and Bank
0.28
0.02
0.26
1,300.00%
Other Current Assets
0.17
0.03
0.14
466.67%
Short Term Loans and Advances
3.06
1.94
1.12
57.73%
Total Current Assets
17.12
15.59
1.53
9.81%
Net Current Assets (Including Current Investments)
1.95
2.64
-0.69
-26.14%
Total Current Assets Excluding Current Investments
17.12
15.59
1.53
9.81%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
19.40
18.23
1.17
6.42%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
7.50
-7.50
-100.00%
Book Value per share (adjusted)
14.46
1.10
13.36
1,214.55%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 17.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025
Footer loading
